APA (7th ed.) Citation

Birkman, E., Elzagheid, A., Jokilehto, T., Avoranta, T., Korkeila, E., Kulmala, J., . . . Sundström, J. (2018). Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer. Cancer Medicine, 7(3), 698. https://doi.org/10.1002/cam4.1361

Chicago Style (17th ed.) Citation

Birkman, Eva‐Maria, Adam Elzagheid, Terhi Jokilehto, Tuulia Avoranta, Eija Korkeila, Jarmo Kulmala, Kari Syrjänen, Jukka Westermarck, and Jari Sundström. "Protein Phosphatase 2A (PP2A) Inhibitor CIP2A Indicates Resistance to Radiotherapy in Rectal Cancer." Cancer Medicine 7, no. 3 (2018): 698. https://doi.org/10.1002/cam4.1361.

MLA (9th ed.) Citation

Birkman, Eva‐Maria, et al. "Protein Phosphatase 2A (PP2A) Inhibitor CIP2A Indicates Resistance to Radiotherapy in Rectal Cancer." Cancer Medicine, vol. 7, no. 3, 2018, p. 698, https://doi.org/10.1002/cam4.1361.